Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05467982 |
Other study ID # |
STUDY00031245 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
October 1, 2020 |
Est. completion date |
April 30, 2022 |
Study information
Verified date |
July 2022 |
Source |
Dartmouth-Hitchcock Medical Center |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The study will enroll 600 people with serious mental illness who receive services at
Centerstone in KY or TN and will compare two different evidence-based self-management
interventions: Integrated Illness Management and Recovery (I-IMR), a program developed by the
study team at Dartmouth that trains people with serious mental illness on physical and mental
health self-management, and the Stanford Chronic Disease Self-Management Program (CDSMP), a
program largely focused on physical health self-management that has been used widely in the
general population. In addition, PCORI is funding an evaluation of a COVID-related
intervention that will begin in the Fall 2020.
Description:
The proposed study will be the first to compare two commonly used but substantially
different, evidence-based self-management interventions. Integrated Illness Management and
Recovery (I-IMR), is an individually-tailored, 16-session, integrated program combining both
physical and mental health self-management specifically developed for people with SMI. In
contrast, the Stanford Chronic Disease Self-Management Program (CDSMP) is a group-based,
6-session, chronic disease self-management program largely focused on physical health
self-management alone. I-IMR is delivered by community mental health providers or by
community outreach workers, while CDSMP is co-delivered by two peers or by a health
professional and a peer. Both programs have been widely recommended, disseminated, and used.
The proposed parent study will randomize people with serious mental illness to I-IMR (n=300)
and CDSMP (n=300).
Our COVID-related Enhancement will involve enrolling 150 participants from the parent project
to an evaluation of an additional I-IMR module compared to usual care during the pandemic.
The I-IMR module will be delivered by trained interventionists in 3 calls over 3 weeks to
n=75 I-IMR participants. The I-IMR participants and CDSMP participants will continue to
receive Usual Care, consisting of generic support calls from clinicians at the study sites.
Baseline, and 6, 9, and 12 week assessments will evaluate the effectiveness of the COVID-19
module that will be added to I-IMR.